KRAS and plasma cell myeloma: In the present study, TAK-580 specifically inhibited the RAS-RAF-MEK-ERK pathway and significantly induced anti-myeloma effects and apoptosis in NRAS-mutated INA-6 and KRAS-mutated RPMI-8226 MM cell lines.